BRCA1 and Alzheimer disease: Neurons treated with amyloid-beta, a peptide critically involved in the pathogenesis of Alzheimer’s disease (AD), exhibit more DNA double-strand breaks (DSBs), based on the accumulation of phosphorylated histone H2A variant X (γH2A.X)15, and less BRCA1, a protein that repairs DSBs19.